Stone House Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.93K Hold
63
– – ﹤0.01% 558
2026
Q1
$5.46K Sell
63
-11
-15% -$1.05K ﹤0.01% 446
2025
Q4
$7.11K Buy
74
+3
+4% +$291 ﹤0.01% 364
2025
Q3
$6.76K Buy
71
+11
+18% +$1.01K ﹤0.01% 330
2025
Q2
$5.23K Hold
60
– – ﹤0.01% 320
2025
Q1
$5.39K Buy
+60
New +$5.37K ﹤0.01% 305
2024
Q4
– Sell
-60
Closed -$5.4K – 226
2024
Q3
$5.4K Hold
60
– – ﹤0.01% 266
2024
Q2
$4.72K Hold
60
– – ﹤0.01% 278
2024
Q1
$5.23K Hold
60
– – ﹤0.01% 285
2023
Q4
$4.94K Sell
60
-193
-76% -$14.7K ﹤0.01% 208
2023
Q3
$19.8K Buy
253
+1
+0.4% +$84 0.01% 120
2023
Q2
$22.2K Buy
252
+200
+385% +$17.2K 0.01% 112
2023
Q1
$4.18K Buy
+52
New +$4.24K ﹤0.01% 211

Other funds holding MDT

Stone House Investment Management's MDT Position: Q2 2026 in Review

Stone House Investment Management held its Medtronic (MDT) position steady in Q2 2026 at 63 shares worth $4.93K. The position accounts for ﹤0.01% of the portfolio, ranked #558.

Stone House Investment Management first reported a position in MDT in Q1 2023 and has held it in 13 quarters since. The position peaked at $22.2K in Q2 2023. 2,148 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Stone House Investment Management held 63 shares of Medtronic worth $4.93K as of Q2 2026.
  • Stone House Investment Management left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #558 holding.
  • Stone House Investment Management first reported a position in Medtronic in Q1 2023 and has held it in 13 quarters since.
  • Stone House Investment Management's Medtronic position peaked at $22.2K in Q2 2023.
  • 2,148 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.